Characterising the histopathology of immunotherapy-induced colitis
Recruiting
- Conditions
- ICI therapy-induced colitis, untreated Crohn’s colitis, untreated Ulcerative colitis, or GvH-colitis following allogenic stem cell transplantation
- Registration Number
- NL-OMON25386
- Lead Sponsor
- niversity Medical Center Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Diagnosis of ICI therapy-induced colitis, Crohn’s colitis, Ulcerative colitis, or GvH-colitis following allogenic stem cell transplantation confirmed by histopathological analysis.
Exclusion Criteria
-Previous treatment of Crohn’s colitis and Ulcerative colitis
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umbers and distribution of CD4+ T cells, CD8+ T cells, and CD68+ macrophages in different hotspots. Variation between hotspots per patients<br>
- Secondary Outcome Measures
Name Time Method